Polymorphism in molecular crystals

Current Opinion in Solid State and Materials Science

Volumn 13, Issue 3-4, 2009, Pages 91-97

  Bond, Andrew D ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Crystallisation; Molecular crystals; Polymorphism

Indexed keywords

CHARACTERISATION; CRYSTALLISATION; MULTI-DISCIPLINARY; POLYMORPHIC COMPOUNDS; POLYMORPHIC SYSTEM; SIMULATION STUDIES; STRUCTURAL INFORMATION;

CRYSTALLIZATION; MOLECULAR CRYSTALS; POLYMORPHISM;

SINGLE CRYSTALS;

EID: 69249206501     PISSN: 13590286     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cossms.2009.06.004     Document Type: Article

References (75)

1. Desiraju G.R. Polymorphism: the same and not quite the same. Cryst Growth Des 8 (2008) 3-5
2. Nangia A. Conformational polymorphism in organic crystals. Acc Chem Res 41 (2008) 595-604
3. Price S.L. Computational prediction of organic crystal structures and polymorphism. Int Rev Phys Chem 27 (2008) 541-568
4. Stahly G.P. Diversity in single- and multiple-component crystals. The search for and prevalence of polymorphs and cocrystals. Cryst Growth Des 7 (2007) 1007-1026
5. Matzger A.J. Facets of polymorphism in crystals. Cryst Growth Des 8 (2008) 2
6. Coquerel G, Roberts KJ. Selected papers from the 7th international conference on the crystal growth of organic materials. Cryst Growth Des 2007;7:1567.
7. Unwin P.R. Crystal growth and nucleation: tracking precursors to polymorphs. Faraday Discuss 136 (2007) 409-416
8. Ruiz B., Coe B.J., Gianotti R., Gramlich V., Jazbinsek M., and Gunter P. Polymorphism, crystal growth and characterization of an organic nonlinear optical material: DAPSH. CrystEngComm 9 (2007) 772-776
9. Kitamura C., Ohara T., Kawatsuki N., Yoneda A., Kobayashi T., Naito H., et al. Conformational polymorphism and optical properties in the solid state of 1, 4, 7, 10-tetra(n-butyl) tetracene. CrystEngComm 9 (2007) 644-647
10. Munshi P., Skelton B.W., McKinnon J.J., and Spackman M.A. Polymorphism in 3-methyl-4-methoxy-4′-nitrostilbene (MMONS), a highly active NLO material. CrystEngComm 10 (2008) 197-206
11. Brillante A., Bilotti I., Della Valle R.G., Venuti E., Milita S., Dionigi C., et al. The four polymorphic modifications of the semiconductor dibenzo-tetrathiafulvalene. CrystEngComm 10 (2008) 1899-1909
12. Pan H., Liu P., Li Y., Wu Y., Ong B.S., Zhu S., et al. Unique polymorphism of oligothiophenes. Adv Mater 19 (2007) 3240-3243
13. Mutai T., Tomoda H., Ohkawa T., Yabe Y., and Araki K. Switching of polymorph-dependent ESIPT luminescence of an imidazo[1,2-a]pyridine derivative. Angew Chem Int Ed 47 (2008) 9522-9524
14. Arod F., Pattisont P., Schenk K.J., and Chapuis G. Polymorphism in N-salicylideneaniline reconsidered. Cryst Growth Des 7 (2007) 1679-1685
15. Braun D.E., Gelbrich T., Jetti R.K.R., Kahlenberg V., Price S.L., and Griesser U.J. Colored polymorphs: thermochemical and structural features of N-picryl-p-toluidine polymorphs and solvates. Cryst Growth Des 8 (2008) 1977-1989
16. Enright G.D., Terskikh V.V., Brouwer D.H., and Ripmeester J.A. The structure of two anhydrous polymorphs of caffeine from single-crystal diffraction and ultrahigh-field solid-state C-13 NMR spectroscopy. Cryst Growth Des 7 (2007) 1406-1410
17. Guzei I.A., Bikzhanova G.A., Spencer L.C., Timofeeva T.V., Kinnibrugh T.L., and Campana C.F. Polymorphism and history of 2-dimethylsufuranylidene-1, 3-indanedione (YLID). Cryst Growth Des 8 (2008) 2411-2418
18. Siegrist T., Besnard C., Haas S., Schiltz M., Pattison P., Chernyshov D., et al. A polymorph lost and found: the high-temperature crystal structure of pentacene. Adv Mater 19 (2007) 2079-2082
19. Barsky I., Bernstein J., Stephens P.W., Stone K.H., Cheung E., Hickey M.B., et al. Disappearing and reappearing polymorphism in p-methylchalcone. Cryst Growth Des 8 (2008) 63-70
20. Das D., and Barbour L.J. Polymorphism of a hexa-host: isolation of four different single-crystal phases by melt crystallization. J Am Chem Soc 130 (2008) 14032-14033
21. Tao J., Jones K.J., and Yu L. Cross-nucleation between d-mannitol polymorphs in sesded crystallization. Cryst Growth Des 7 (2007) 2410-2414
22. Yu L. Survival of the fittest polymorph: how a fast nucleater can lose to fast grower. CrystEngComm 9 (2007) 847-851
23. Parmar M.M., Khan O., Seton L., and Ford J.L. Polymorph selection with morphology control using solvents. Cryst Growth Des 7 (2007) 1635-1642
24. Chiarella R.A., Gillon A.L., Burton R.C., Davey R.J., Sadiq G., Auffret A., et al. The nucleation of inosine: the impact of solution chemistry on the appearance of polymorphic and hydrated crystal forms. Faraday Discuss 136 (2007) 179-193
25. Cox J.R., Ferris L.A., and Thalladi V.R. Selective growth of a stable drug polymorph by suppressing the nucleation of corresponding metastable polymorphs. Angew Chem Int Ed 46 (2007) 4333-4336
26. Dabros M., and Thalladi V.R. Effect of alkyl chain parity on the face-selective crystal growth of a drug polymorph. Chem Commun (2007) 2476-2478
27. Dressler D.H., and Mastai Y. Controlling polymorphism by crystallization on self-assembled multilayers. Cryst Growth Des 7 (2007) 847-850
28. Kelleher J.M., Lawrence S.E., McAuliffe M.T., and Moynihan H.A. Monomeric and polymeric derivatives of 5-aminoisophthalic acid as selective inhibitors of the beta-polymorph of l-glutamic acid. CrystEngComm 9 (2007) 72-77
29. Chen J., and Trout B.L. Computational study of solvent effects on the molecular self-assembly of tetrolic acid in solution and implications for the polymorph formed from crystallization. J Phys Chem B 112 (2008) 7794-7802
30. Beckham G.T., Peters B., Starbuck C., Variankaval N., and Trout B.L. Surface-mediated nucleation in the solid-state polymorph transformation of terephthalic acid. J Am Chem Soc 129 (2007) 4714-4723
31. Beckham G.T., Peters B., and Trout B.L. Evidence for a size dependent nucleation mechanism in solid state polymorph transformations. J Phys Chem B 112 (2008) 7460-7466
32. Anwar J., Tuble S.C., and Kendrick J. Concerted molecular displacements in a thermally-induced solid-state transformation in crystals of dl-norleucine. J Am Chem Soc 9 (2007) 2542-2547
33. Day G.M., Cooper T.G., Cruz-Cabeza A.J., Hejczyk K.E., Ammon H.L., Boerrigter S.X.M., et al. Significant progress in predicting the crystal structures of small organic molecules: a report on the fourth blind test. Acta Cryst B65 (2009) 107-125
34. Neumann M.A., Leusen F.J.J., and Kendrick J. A major advance in crystal structure prediction. Angew Chem Int Ed 47 (2008) 2427-2430
35. Perrin MA, Neumann MA, Elmaleh H, Zaske L. Crystal structure determination of the elusive paracetamol Form III. Chem Commun 2009:3181-3183.
36. Linol J., Morelli T., Petit M.N., and Coquerel G. Inversion of the relative stability between two polymorphic forms of (±) modafinil under dry high-energy milling: comparisons with results obtained under wet high-energy milling. Cryst Growth Des 7 (2007) 1608-1611
37. Sreekanth B.R., Vishweshwar P., and Vyas K. Supramolecular synthon polymorphism in 2:1 co-crystal of 4-hydroxybenzoic acid and 2, 3, 5, 6-tetramethylpyrazine. Chem Commun (2007) 2375-2377
38. Babu N.J., Reddy L.S., Aitipamula S., and Nangia A. Polymorphs and polymorphic cocrystals of temozolomide. Chem Asian J 3 (2008) 1122-1133
39. Gryl M., Krawczuk A., and Stadnicka K. Polymorphism of urea-barbituric acid co-crystals. Acta Cryst B64 (2008) 623-632
40. Braga D., Palladino G., Polito M., Rubini K., Grepioni F., Chierotti M.R., et al. Three polymorphic forms of the co-crystal 4, 4 '-bipyridine/pimelic acid and their structural, thermal, and spectroscopic characterization. Chem Eur J 14 (2008) 10149-10159
41. Porter W.W., Elie S.C., and Matzger A.J. Polymorphism in carbamazepine cocrystals. Cryst Growth Des 8 (2008) 14-16
42. ter Horst J.H., and Cains P.W. Co-crystal polymorphs from a solvent-mediated transformation. Cryst Growth Des 8 (2008) 2537-2542
43. Wishkerman S., and Bernstein J. Polymorphism and structural mechanism of the phase transformation of phenyl carbamate (PC). Chem Eur J 14 (2008) 197-203
44. Lancaster R.W., Karamertzanis P.G., Hulme A.T., Tocher D.A., Lewis T.C., and Price S.L. The polymorphism of progesterone: stabilisation of a "disappearing" polymorph by co-crystallisation. J Pharm Sci 96 (2007) 3419-3431
45. Yamashita M., Inomata S., Ishikawa K., Kashiwagi T., Matsuo H., Sawamura S., et al. A high-pressure polymorph of l-alpha-leucine. Acta Cryst E63 (2007) o2762-o2764
46. Johnstone R.D.L., Francis D., Lennie A.R., Marshall W.G., Moggach S.A., Parsons S., et al. High-pressure polymorphism in l-serine monohydrate: identification of driving forces in high-pressure phase transitions and possible implications for pressure-induced protein denaturation. CrystEngComm 10 (2008) 1758-1769
47. Fabbiani F.P.A., Allan D.R., David W.I.F., Davidson A.J., Lennie A.R., Parsons S., et al. High-pressure studies of pharmaceuticals: an exploration of the behavior of piracetam. Cryst Growth Des 7 (2007) 1115-1124
48. Dziubek K., and Podsiadło Katrusiak.A. Nearly isostructural polymorphs of ethynylbenzene: resolution of CH π(arene) and cooperative CH π(C{triple bond, long}C) interactions by pressure freezing. J Am Chem Soc 129 (2007) 12620-12621
49. Boldyreva E. High-pressure polymorphs of molecular solids: when are they formed, and when are they not? Some examples of the role of kinetic control. Cryst Growth Des 7 (2007) 1662-1668
50. Ibberson R.M., Parsons S., Allan D.R., and Bell A.M.T. Polymorphism in cyclohexanol. Acta Cryst. B64 (2008) 573-582 [corrigendum 791]
51. Wöhler F, Liebig, J. Investigation of the radical of benzoic acid. Ann. Pharm. 1832:249-282.
52. Blagden N., Davey R., Dent G., Song M., David W.I.F., Pulham C.R., et al. Wöhler and Liebig revisited: a small molecule reveals its secrets. The crystal structure of the unstable polymorph of benzamide solved after 173 years. Cryst Growth Des 5 (2005) 2218-2224
53. Thun J., Seyfarth L., Senker J., Dinnebier R.E., and Breu J. Polymorphism in benzamide: solving a 175-year-old riddle. Angew Chem Int Ed 46 (2007) 6729-6731
54. Hughes C.E., Hamad S., Harris K.D.M., Catlow C.R.A., and Griffiths P.C. A multi-technique approach for probing evolution of structural properties during crystallisation of organic materials from solutions. Faraday Trans 136 (2007) 71-89
55. Hamad S., Hughes C.E., Catlow C.R.A., and Harris K.D.M. Clustering of glycine molecules in aqueous solution by molecular dynamics simulation. J Phys Chem B 112 (2008) 7280-7288
56. Huang J., Stringfellow T.C., and Yu L. Glycine exists mainly as monomers, not dimers, in supersaturated aqueous solutions: implications for understanding its crystallization and polymorphism. J Am Chem Soc 130 (2008) 13973-13980
57. Xu M., and Harris K.D.M. Alteration of polymorphic selectivity through different crystallization mechanisms occurring in the same crystallization solution. J Phys Chem B 111 (2007) 8705-8707
58. Capes J.S., and Cameron R.E. Contact line crystallisation to obtain metastable polymorphs. Cryst Growth Des 7 (2007) 108-112
59. Poornachary S.K., Chow P.S., and Tan R.B.H. Influence of solution speciation of impurities on polymorphic nucleation in glycine. Cryst Growth Des 8 (2008) 179-185
60. Yang X., Lu J., Wang X.J., and Ching C.B. Effect of sodium chloride on the nucleation and polymorphic transformation of glycine. J Cryst Growth 310 (2008) 604-611
61. Lee E.H., Boerrigter S.X.M., Rumondor A.C.F., Chamarthy S.P., and Byrn S.R. Formation and solid-state characterization of a salt-induced metastable polymorph of flufenamic acid. Cryst Growth Des 8 (2008) 91-97
62. Chew J.W., Black S.N., Chow P.S., Tan R.B.H., and Carpenter K.J. Stable polymorphs: difficult to make and difficult to predict. CrystEngComm 9 (2007) 128-130
63. Di Profio G., Tucci S., Curcio E., and Drioli E. Selective glycine polymorph crystallization by using microporous membranes. Cryst Growth Des 7 (2007) 526-530
64. Di Profio G., Tucci S., Curcio E., and Drioli E. Controlling polymorphism with membrane-based crystallizers: application to form I and II of paracetamol. Chem Mater 19 (2007) 2386-2388
65. Hamilton B.D., Hillmyer M.A., and Ward M.D. Glycine polymorphism in nanoscale crystallization chambers. Cryst Growth Des 8 (2008) 3368-3375
66. Hammond R.B., Pencheva K., and Roberts K.J. An examination of polymorphic stability and molecular conformational flexibility as a function of crystal size associated with the nucleation and growth of benzophenone. Faraday Discuss 136 (2007) 91-106
67. Ouvrard C., and Price S.L. Toward crystal structure prediction for conformationally flexible molecules: the headaches illustrated by aspirin. Cryst Growth Des 4 (2004) 1119-1127
68. Vishweshwar P., McMahon J.A., Oliveira M., Peterson M.L., and Zaworotko M.J. The predictably elusive form II of aspirin. J Am Chem Soc 127 (2005) 16802-16803
69. Bond A.D., Boese R., and Desiraju G.R. On the polymorphism of aspirin. Angew Chem Int Ed 46 (2007) 615-617
70. Bond A.D., Boese R., and Desiraju G.R. On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains. Angew Chem Int Ed 46 (2007) 618-622
71. Copley R.C.B., Barnett S.A., Karamertzanis P.G., Harris K.D.M., Kariuki B.M., Xu M.C., et al. Predictable disorder versus polymorphism in the rationalization of structural diversity: a multidisciplinary study of eniluracil. Cryst Growth Des 8 (2008) 3474-3481
72. Bhatt P.M., and Desiraju G.R. Tautomeric polymorphism in omeprazole. Chem Commun (2007) 2057-2059
73. Bond A.D. What is a co-crystal?. CrystEngComm 9 (2007) 833-834
74. Vujovic D., and Nassimbeni L.R. Methyl paraben: a new polymorph?. Cryst Growth Des 6 (2006) 1595-1597
75. Threlfall T.L., and Gelbrich T. The crystal structure of methyl paraben at 118 K does not represent a new polymorph. Cryst Growth Des 7 (2007) 2297